Close Menu

A Palo Alto company could be poised to potentially change the existing laboratory testing model for consumers, the San Francisco Business Times reports. 

Theranos has been offering tests based on a pin prick's worth of blood in Walgreens in the Phoenix area and one in Palo Alto, California for routine analysis such as blood cholesterol levels and diabetes, without a physician's order. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.